These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 15973159)
1. Neuroprotection of Parkin against apoptosis is independent of inclusion body formation. Yang H; Zhou HY; Li B; Chen SD Neuroreport; 2005 Jul; 16(10):1117-21. PubMed ID: 15973159 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin. Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. Avraham E; Rott R; Liani E; Szargel R; Engelender S J Biol Chem; 2007 Apr; 282(17):12842-50. PubMed ID: 17327227 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of parkin damages antioxidant defenses and enhances proteasome inhibition-induced toxicity in PC12 cells. Yang H; Zhou HY; Li B; Niu GZ; Chen SD J Neuroimmune Pharmacol; 2007 Sep; 2(3):276-83. PubMed ID: 18040862 [TBL] [Abstract][Full Text] [Related]
5. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850 [TBL] [Abstract][Full Text] [Related]
7. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595 [TBL] [Abstract][Full Text] [Related]
8. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198 [TBL] [Abstract][Full Text] [Related]
10. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477 [TBL] [Abstract][Full Text] [Related]
11. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases? Lim KL; Dawson VL; Dawson TM Neurobiol Aging; 2006 Apr; 27(4):524-9. PubMed ID: 16213628 [TBL] [Abstract][Full Text] [Related]
12. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates. Gu WJ; Corti O; Araujo F; Hampe C; Jacquier S; Lücking CB; Abbas N; Duyckaerts C; Rooney T; Pradier L; Ruberg M; Brice A Neurobiol Dis; 2003 Dec; 14(3):357-64. PubMed ID: 14678753 [TBL] [Abstract][Full Text] [Related]
13. Involvement of spinal motor neurons in parkin-positive autosomal recessive juvenile parkinsonism. Sasaki S; Shirata A; Yamane K; Iwata M Neuropathology; 2008 Feb; 28(1):74-80. PubMed ID: 18031467 [TBL] [Abstract][Full Text] [Related]
14. Parkin is linked to the ubiquitin pathway. Tanaka K; Suzuki T; Chiba T; Shimura H; Hattori N; Mizuno Y J Mol Med (Berl); 2001 Sep; 79(9):482-94. PubMed ID: 11692161 [TBL] [Abstract][Full Text] [Related]
15. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. Rideout HJ; Larsen KE; Sulzer D; Stefanis L J Neurochem; 2001 Aug; 78(4):899-908. PubMed ID: 11520910 [TBL] [Abstract][Full Text] [Related]
16. Molecular interaction between parkin and PINK1 in mammalian neuronal cells. Um JW; Stichel-Gunkel C; Lübbert H; Lee G; Chung KC Mol Cell Neurosci; 2009 Apr; 40(4):421-32. PubMed ID: 19167501 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease. Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394 [TBL] [Abstract][Full Text] [Related]
18. Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults. Hyun DH; Lee M; Halliwell B; Jenner P J Neurosci Res; 2005 Oct; 82(2):232-44. PubMed ID: 16130151 [TBL] [Abstract][Full Text] [Related]
19. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease. Yasuda T; Mochizuki H Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696 [TBL] [Abstract][Full Text] [Related]
20. A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death. Imai Y; Soda M; Murakami T; Shoji M; Abe K; Takahashi R J Biol Chem; 2003 Dec; 278(51):51901-10. PubMed ID: 14532270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]